Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL107845

CCCC[N+](CCCC)(CCCC)CCCC.O=C([O-])C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 3/20 0.52
FAAH O00519 8/20 0.48
CES1 P23141 5/20 0.47
CES2 O00748 3/20 0.47
MEN1 O00255 1/20 0.47
CYP1A2 P05177 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
SLC22A2 O15244 1/20 0.46
EPHX1 P07099 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrapentylammonium SCHEMBL15355495 0.96 SLC22A1 (0.52) SLC22A1FAAHCES1CES2MEN1
Tetrahexylammonium SCHEMBL15355454 0.94 SLC22A1 (0.54) SLC22A1FAAHCES1CES2MEN1
Trifluoroacetic Acid SCHEMBL27963939 0.92 DNM1 (0.46) SLC22A1FAAHCES1CES2MEN1
Tetrabuthylammonium SCHEMBL10529094 0.88 SLC22A1 (0.48) SLC22A1FAAHCES1CES2MEN1
Tetrapropylammonium SCHEMBL107306 0.86 SLC22A1 (0.48) SLC22A1FAAHCES1CES2MEN1
Tetrabuthylammonium SCHEMBL10527770 0.86 SLC22A1 (0.46) SLC22A1FAAHCES1CES2MEN1
Trifluoroacetic Acid SCHEMBL1981477 0.85 DNM1 (0.44) FAAHCES1CES2MEN1CYP1A2
Trifluoroacetic Acid SCHEMBL34745 0.85 FAAH (0.44) SLC22A1FAAHCES1CES2SLC22A2
Tetrabuthylammonium SCHEMBL2350563 0.84 SLC22A1 (0.55) SLC22A1CES1CES2HSD17B10SLC22A2
Tetrabuthylammonium SCHEMBL17353521 0.84 SLC22A1 (0.55) SLC22A1FAAHCES1CES2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111856882-B Composition for forming silicon-containing resist underlayer film and pattern forming method 信越化学工业株式会社 2024-11-29 CN claimed
CN-117015282-A Method for optimizing perovskite film, perovskite film obtained by method and application of perovskite film 极电光能有限公司 2023-11-07 CN claimed
US-11603321-B2 Rechargeable aluminum ion battery EVERON24, INC. (US) 2023-03-14 US claimed
US-11480879-B2 Composition for forming silicon-containing resist underlayer film and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2022-10-25 US claimed
CN-111389046-B Extraction agent and method for extracting astaxanthin by using same 广东海洋大学 2021-08-24 CN claimed
CN-111389046-A Extraction agent and method for extracting astaxanthin by using same 广东海洋大学 2020-07-10 CN claimed
EP-2014738-B1 Adhesive composition and optical member CHEIL IND INC (KR) 2020-04-01 EP claimed
EP-3526878-A1 RECHARGEABLE ALUMINUM ION BATTERY Everon24 LLC (US) 2019-08-21 EP claimed
US-20180138554-A1 Rechargeable Aluminum Ion Battery Alsym Energy, Inc. 2018-05-17 US claimed
US-8575245-B2 Tunable polymer compositions NOVOMER, INC. (US) 2013-11-05 US claimed
US-8217100-B2 Adhesive composition and optical member CHEIL INDUSTRIES, INC. (KR) 2012-07-10 US claimed
US-20090014123-A1 Adhesive composition and optical member Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) 2009-01-15 US claimed
EP-0720599-B1 HYDROXY-SUBSTITUTED AZETIDINONE COMPOUNDS USEFUL AS HYPOCHOLESTEROLEMIC AGENTS SCHERING CORP (US) 1999-05-19 EP claimed
US-4867790-A DELAYED POLYMERIZATION, SULFONIUM INITIATOR ESPE STIFTUNG & CO. PRODUKTIONS- UND VERTRIEBS KG (DE) 1989-09-19 US claimed
JP-6256473-A None JP disclosed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
EP-4700067-A1 COMPOSITION FOR FORMING SILICON-CONTAINING FILM, METHOD FOR FORMING FILM, AND SUPERSTRATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-25 EP disclosed
CN-85103245-A The preparation of chirality rhodium-diphosphonic complex and the application in asymmetric hydrogenation thereof 1986-12-24 CN disclosed
EP-0158875-A2 Chiral-rhodium-diphosphine complexes for asymetric hydrogenations F. HOFFMANN-LA ROCHE AG (CH) 1985-10-23 EP disclosed
US-4024032-A AROMATIC SUBSTRATE, CARBOXYLIC ACID HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1977-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 SLC22A1 4619/4885FAAH 4562/4885CES1 2618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.